These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5916005)

  • 21. [Effects of morphazinamide in the treatment of bronchial diseases in the course of tuberculosis].
    Bonarrigo N; Bonsignore G
    Minerva Med; 1965 Sep; 56(70):2811-8. PubMed ID: 5852639
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical results of morphazinamide therapy in tubercular disease].
    Loschiavo F
    Minerva Med; 1965 Sep; 56(70):2844-6. PubMed ID: 5852642
    [No Abstract]   [Full Text] [Related]  

  • 23. [Criteria of the application of morphazinamide in antitubercular therapy].
    Agostini U
    Minerva Med; 1967 Feb; 58(14):526-7. PubMed ID: 6021420
    [No Abstract]   [Full Text] [Related]  

  • 24. [On treatment of tubercular lymphadenitis with morphazinamide. Clinical, pathogenetic and therapeutic particulars of 2 cases].
    Insinna F
    Minerva Med; 1965 Sep; 56(70):2846-9. PubMed ID: 5852643
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapeutic use of morphazinamide in certain forms of tuberculous meningitis].
    Barba G; Bruno F
    Minerva Med; 1966 Oct; 57(83):3386-92. PubMed ID: 5924862
    [No Abstract]   [Full Text] [Related]  

  • 26. [Level of blood serum level of uric acid in tuberculous patients treated with morphazinamide].
    Wawrzeńczyk B; Zaruski A
    Gruzlica; 1973 Feb; 41(2):177-80. PubMed ID: 4695789
    [No Abstract]   [Full Text] [Related]  

  • 27. [Behavior of some hematochemical data and of the most important biological indexes of disease and of phase in subjects affected by pulmonary tuberculosis treated with morphazinamide].
    Caltagirone S
    Minerva Med; 1965 Sep; 56(70):2766-71. PubMed ID: 5322265
    [No Abstract]   [Full Text] [Related]  

  • 28. [Morphazinamide in antitubercular therapy. 2 years of clinical experimentation].
    Fouquet J; Teyssier L
    Minerva Med; 1965 Sep; 56(71):2898-900. PubMed ID: 5322272
    [No Abstract]   [Full Text] [Related]  

  • 29. [ANTITUBERCULAR ACTION OF MORPHAZINAMIDE].
    ANZALONE M
    G Ital Chemioter; 1963; 10():229-30. PubMed ID: 14079412
    [No Abstract]   [Full Text] [Related]  

  • 30. [On the intrapleural and intrabronchial administration of morphazinamide administered alone and in association with dexamethasone 21-orthophosphate].
    Oncina E
    Minerva Med; 1965 Sep; 56(70):2818-20. PubMed ID: 5852640
    [No Abstract]   [Full Text] [Related]  

  • 31. [Morphazinamide--clinical tolerance and side effects].
    Lachowicz D; Siekierzyńska A; Styszewska H
    Gruzlica; 1967 May; 35(5):453-63. PubMed ID: 6056260
    [No Abstract]   [Full Text] [Related]  

  • 32. [CLINICAL AND EXPERIMENTAL DATA ON THE USE OF MORPHAZINAMIDE IN TUBERCULAR INFECTION].
    BLASI A; BERTI R; MORI G
    G Ital Chemioter; 1963; 10():201-3. PubMed ID: 14079403
    [No Abstract]   [Full Text] [Related]  

  • 33. Tuberculostatic activity of N-morpholino-4'-méthylamide pyrazincarbonic acid on experimental tuberculosis in mice.
    Verbist L
    Acta Tuberc Pneumol Belg; 1966; 57(3):211-7. PubMed ID: 5985965
    [No Abstract]   [Full Text] [Related]  

  • 34. [THE CAUSATIVE RELATION BETWEEN THE TUBERCULOSTATIC EFFECTIVENESS OF MORPHAZINAMIDE AND ITS INSTABILITY].
    BOENICKE R
    G Ital Chemioter; 1963; 10():190-5. PubMed ID: 14079401
    [No Abstract]   [Full Text] [Related]  

  • 35. [EXPERIMENTAL RESEARCH ON THE ANTITUBERCULAR ACTION OF MORPHAZINAMIDE].
    LUCCHESI M
    G Ital Chemioter; 1963; 10():58-64. PubMed ID: 14079392
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of injectable morphazinamide in the therapy of pleurisy].
    Censi G; Orlandini GC
    G Ital Mal Torace; 1966; 20(2):91-101. PubMed ID: 5942328
    [No Abstract]   [Full Text] [Related]  

  • 37. [EXPERIMENTAL TESTS "IN VIVO" ON THE ANTIMYCOBACTERIAL ACTION OF MORPHAZINAMIDE].
    BLASI A
    G Ital Chemioter; 1963; 10():51-5. PubMed ID: 14085318
    [No Abstract]   [Full Text] [Related]  

  • 38. [Latest observations in man experimental animals on hepatic function, gastric secretion and blood uric acid in the course of therapy with morphazinamide].
    Mariani B
    Minerva Med; 1965 Sep; 56(70):2782-8. PubMed ID: 5852636
    [No Abstract]   [Full Text] [Related]  

  • 39. [The virulence of resistance strains of Mycobacterium tuberculosis for guinea pigs and experimental therapeutic effects of antitubercular agents on the animals infected by the resistant strains. II. Experimental therapeutic effect on guinea pigs infected by resistant strains of Mycobacterium tuberculosis].
    Yan BS
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1982 Aug; 5(4):206-8. PubMed ID: 6816558
    [No Abstract]   [Full Text] [Related]  

  • 40. Results obtained with morphazinamide in the treatment of leprosy.
    Opromolla DV
    Chemotherapy; 1966; 11(5):270-84. PubMed ID: 5958715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.